Please login to the form below

Creative review: ESMO 2018

BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an inspiring design for your booth.

On October 19th the team from Blue Latitude Health flew to Munich to attend the European Society for Medical Oncology (ESMO) 2018 Congress and deliver an innovative and immersive booth for a client. This year’s theme focused on securing access to optimal cancer care – a poignant topic and one that resonates across the healthcare sector, impacting patients in all walks of life.

The booths were bigger and better than ever, with organisations and brands using innovative techniques to stave off the competition and showcase scientific breakthroughs. Here, we analyse the creative concepts and explain which organisations impressed us the most and why, along with our recommendations for creating an inspiring space that draws in the crowds.

Best underdog: Ipsen Pharma

One of the biggest challenges for smaller pharma companies is to make the most of the booth’s position, especially when the prime locations in the exhibition hall are often far more expensive than the slots positioned in the outskirts.

Ipsen Group developed an eye-catching attraction to offset this challenge. The booth showcased a single study for a metastatic pancreatic cancer therapy and the brand chose to unite the booth in a single alpine theme. To make an impact, they developed a large statue of a ram, which when viewed up close was made out of individual molecules (pictured right).

These molecules came together as an imposing rams head, with spiralling horns which rose over the hall. The sheer size and striking design of the 3D figure highlighted the location of the booth, with the statue towering above the competing stalls. As a result, the booth enticed oncologists, giving the organisation a greater platform to showcase the brand’s data.

Best attractor: Bayer

It’s not just the beauty of Bayer’s installation that grabbed our attention, it was also the way it was used to tie together a cohesive theme.

Often, it is difficult to unite a PR and comms campaign with the commercial elements needed to “sell in” products. Bayer developed a transfixing fan installation, in which large pieces of sheer fabric flew into the air, knotting together in a hypnotic display (pictured left).

This not only drew in crowds, it connected to a campaign which focused on the way the company’s products are “transforming the lives of people impacted by cancer, through science.” To cement this message, HCPs were asked to label ribbons with what inspires them most and the ribbons were hung on the edge of the fan.

Bayer connected this to a wider campaign, which marked the five-year anniversary of one of its brands by “celebrating” patients. The company asked HCPs to commemorate a patient, and these stories were shown via an eye-catching digital interactive display.

The booth was a successful example of not only using an attractor to engage oncologists, but also uniting it with a wider emotive theme, creating symbiosis between the organisation’s ethos and products – a challenging task.

Download the full article here

4th January 2019

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Three strategies for managing loss of exclusivity successfully
Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health